DG-041
DG-041 is a potent and selective EP3 receptor antagonist, exhibiting IC50 values of 4.6 nM and 8.1 nM in binding and functional assays, respectively. It effectively inhibits PGE2-mediated platelet aggregation in vitro and demonstrates blood-brain barrier permeability, supporting its utility in researching thrombosis and neuroinflammatory models.
Product Specifications
CAS Number
861238-35-9
Product Name Alternative
Blood-brain, barrier, atherothrombosis, atherosclerotic, DG041, DG-041, DG 041, infarction, Myocardial, inhibit, EP3 receptor, EP3, Inhibitor, stroke, plaque, Prostaglandin Receptor, ProstaglandinReceptor
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
97.25% (May vary between batches)
Solubility
DMSO:55 mg/mL (92.86 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.38 mM)
Smiles
Cc1cn (Cc2ccc (Cl) cc2Cl) c2c (\C=C\C (=O) NS (=O) (=O) c3cc (Cl) c (Cl) s3) cc (F) cc12
Molecular Formula
C23H15Cl4FN2O3S2
Molecular Weight
592.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
FT67280-01 0.1 g
1- (3,4,5-Trimethoxyphenyl) -piperazine hydrochloride
Sign In for Pricing
View Details 
FT67280-02 0.25 g
1- (3,4,5-Trimethoxyphenyl) -piperazine hydrochloride
Sign In for Pricing
View Details FT67280-03 0.5 g
1- (3,4,5-Trimethoxyphenyl) -piperazine hydrochloride
Sign In for Pricing
View Details FT67280-04 1 g
1- (3,4,5-Trimethoxyphenyl) -piperazine hydrochloride
Sign In for Pricing
View Details